Skip to content
Vaccines have changed the course of human history as we know it. Since the first vaccine was discovered in the late 1700s, vaccine technology […]
What does the vaccine pipeline look like – and how can we strengthen it? Read More »
The World Economic Forum (WEF) wrapped up its annual meeting in Davos last week, with global government and business leaders discussing the most pressing
Davos 2024: key takeaways on food, climate, and health Read More »
Four years after the start of the pandemic, it is well known that COVID-19 is linked with thrombosis. A new report from the Centers
CDC report: up-to-date COVID-19 vaccinations can protect against severe outcomes Read More »
Biotechnology can play a key role in improving human health and a better environment, help us curb food insecurity, and strengthening energy security while
We’re on the brink of a biotech ‘revolution,’ says NSCEB report Read More »
Recently, it’s seemed like everyone has been sick this winter—an observation that is not too far off. This year’s COVID surge is the second-highest
RSV recap: what to know about immunizations and safety in 2024 Read More »
J.P. Morgan’s massive Healthcare Conference wrapped last week. BIO was busy as ever in San Francisco, connecting companies with potential partners, discussing innovation, and
2024 JPM Healthcare Conference: top 5 BIO takeaways Read More »
After two decades of research and development, Sutro Biopharma is still a few years away from seeking market approval for its first drug, a
Loss of tax incentive for R&D threatens biotech innovation Read More »
Brad Bailey is Senior Vice President and U.S. General Manager for Genmab, a global biotechnology company at the forefront of discovering, developing, and delivering
Paving the way for patient-centricity in 2024 Read More »
National wastewater viral activity levels for COVID-19 have been very high since December. (It wasn’t your imagination that everyone seemed sick over the holidays.)
With the new COVID surge, are we really post-pandemic? Read More »
After the Food and Drug Administration (FDA) approved Gilead’s HIV/AIDS drug in 2001, the firm gained FDA approval for a second drug in 2015.
BIO says suit over speed of drug development is threat to innovation and new cures Read More »
